Color’s Post

We have recently developed a new AI tool—designed in partnership with OpenAI and powered by GPT-4o—to make access to cancer expertise more equitable. This AI tool will allow clinicians to bring specialized cancer knowledge into primary care, helping them build risk-adjusted screening recommendations and effectively manage treatment timelines. With the help of partners like OpenAI, we are continuing to make cancer detection and care accessible to more people. Read the full story here: https://lnkd.in/gAVc7gn3

Innovative employers are bringing new screening technologies, like skin cancer detection apps and at-home tests for various cancers, directly to their teams. No more scheduling headaches or long waits. These novel screening methods are making early detection easier and more accessible than ever. And it's not just about convenience—it's also about saving lives. Read more here: https://lnkd.in/gqrFPqWr

Rural communities face a disproportionately higher colorectal cancer mortality rate compared to urban areas. To address this gap, the American Cancer Society and Color Health will be distributing free at-home screening kits through select health centers and clinics, bringing vital early detection tools directly to those who need them most. With full patient support from testing to results, it's an important step towards health equity in cancer care. Read the news here: https://lnkd.in/gEdHYUYw Learn more: https://lnkd.in/gtmsMcqV #RuralHealth #HealthEquity

"While it is imperative that employers adopt strategies to address treatment cost, it is equally important that they amplify efforts to increase cancer prevention and early detection via screening approaches.” - Business Group on Health It's clear. The status quo of cancer care isn't cutting it. Today, the BGH released it's annual survey, which revealed alarming trends. Cancer remains the top cost driver for employers, with projected healthcare spending spiraling 50% since 2017. 📈 Just as concerning? We're seeing cancer strike younger populations, while treatment costs for cutting-edge therapies soar. At Color, we're helping employers take control of cancer by driving in-year savings and providing holistic, patient-centered care. To access the BGH report summary, click on the link: https://lnkd.in/eFcTSpzB. And to learn how our program actively manages care before and beyond a diagnosis, contact us at learnmore@color.com

AI is revolutionizing cancer care, addressing complexities that often delay diagnoses and treatment. With limited expertise at most points of care, gaps can lead to later diagnoses—impacting your workforce and costs. Join us on August 22nd to explore how Color uses AI for personalized screening and streamlined diagnostics. Learn how these innovations are reshaping patient care before the first oncology appointment. Register today: https://lnkd.in/g95e_n2s

A groundbreaking new American Cancer Society study found a pronounced increase in 17 out of 34 cancer types among Millennials and Gen Xers compared to previous generations. Dr. Karen Knudsen, CEO of the American Cancer Society discussed the report on PBS NewsHour, where she advised:   "Don't ignore symptoms. If you're 44 years old and you're experiencing something that seems like it could be associated with colorectal cancer risk, don't wait. Be seen and have that discussion with your physician, even if you're too young to technically have had your first colonoscopy.” Watch the full interview here: https://lnkd.in/gUzvNNbh

American Cancer Society CEO Karen Knudsen MBA PhD and Color CEO Othman Laraki are sounding the alarm: "We have a generational problem" in cancer detection. The bold vision: • Recognize under-50s as the new face of rising cancer rates  • Get screenings to under-50s in ways more convenient to them - including through their employers directly  • Make sure younger individuals know and act on their personal cancer risk, including family history and lifestyle It's time to shatter the "too young to get screened for cancer" myth. Read more in the latest feature by Scientific American https://lnkd.in/gUUsknWG

A recent Annals of Internal Medicine report estimates the annual cost of cancer screening in the U.S. at $43B. But that finding — and the assumptions it triggers — skews the larger reality that: • Screening represents just 17% of total cancer care costs • Early detection significantly reduces treatment expenses • Cancer mortality rates dropped 2.1% annually from 2015-2019 We dig into the numbers to uncover a clearer picture here:  https://lnkd.in/gtBudr3c

New research published in JAMA Oncology shows that aspirin could be a significant preventive measure for individuals at high risk for colorectal cancer. But it's not a silver bullet. Personalized screening plans, lifestyle changes, and fast time to treatment remain crucial. All can impact your population health strategy. https://lnkd.in/eK76eWtP?

Employers take note: That cancer benefits initiative that’s been stalled? It can't wait any longer. A groundbreaking new study from our partners at the American Cancer Society reveals alarming cancer trends in younger workers. Learn how this affects your workforce, and what actions you and your employees can take now: https://lnkd.in/ePyMXcT4